C1GALT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.490100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.616100E-02
Normal-vs-Stage2
7.494400E-02
Normal-vs-Stage3
3.239200E-01
Normal-vs-Stage4
8.180400E-02
Stage1-vs-Stage2
5.536400E-01
Stage1-vs-Stage3
3.343400E-01
Stage1-vs-Stage4
3.416000E-01
Stage2-vs-Stage3
5.322800E-01
Stage2-vs-Stage4
6.792100E-02
Stage3-vs-Stage4
2.158600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.766400E-02
Normal-vs-AfricanAmerican
4.764000E-02
Normal-vs-Asian
5.526200E-02
Caucasian-vs-AfricanAmerican
3.448400E-01
Caucasian-vs-Asian
1.686210E-02
AfricanAmerican-vs-Asian
5.509800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.748400E-02
Normal-vs-Female
7.734400E-02
Male-vs-Female
9.330600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.961600E-02
Normal-vs-Age(41-60Yrs)
3.069900E-02
Normal-vs-Age(61-80Yrs)
1.406790E-01
Normal-vs-Age(81-100Yrs)
8.635700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.564800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.245200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.617000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.351800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.665600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.959200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.357850E-01
Normal-vs-Daily Drinker
1.270570E-01
Normal-vs-Weekly Drinker
1.061960E-01
Normal-vs-Occasional Drinker
3.508200E-02
Normal-vs-Social Drinker
7.330500E-02
Non Drinker-vs-Daily Drinker
5.958200E-01
Non Drinker-vs-Weekly Drinker
6.270200E-01
Non Drinker-vs-Occasional Drinker
7.113000E-01
Non Drinker-vs-Social Drinker
6.823200E-01
Daily Drinker-vs-Weekly Drinker
3.366200E-01
Daily Drinker-vs-Occasional Drinker
3.357600E-01
Daily Drinker-vs-Social Drinker
9.349000E-01
Weekly Drinker-vs-Occasional Drinker
8.506000E-01
Weekly Drinker-vs-Social Drinker
3.919000E-01
Occasional Drinker-vs-Social Drinker
3.806000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.259790E-01
Normal-vs-Grade 2
5.819700E-02
Normal-vs-Grade 3
7.474300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.421000E-01
Grade 1-vs-Grade 3
1.840050E-01
Grade 1-vs-Grade 4
1.259790E-01
Grade 2-vs-Grade 3
6.390200E-01
Grade 2-vs-Grade 4
5.819700E-02
Grade 3-vs-Grade 4
7.474300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.301000E-01
Normal-vs-NonDiabetic
7.355800E-02
Diabetic-vs-NonDiabetic
3.992500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.197800E-02
Normal-vs-NoPancreatitis
1.186590E-01
Pancreatitis-vs-NoPancreatitis
9.008200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.955800E-02
Normal-vs-N1
8.688200E-02
N0-vs-N1
7.837800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.551600E-02
Normal-vs-TP53-NonMutant
7.584100E-02
TP53-Mutant-vs-TP53-NonMutant
7.043500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
